Deferred Systemic Therapy (DST) for Metastatic Renal Cell Carcinoma:  Preliminary Prospective Experience

Deferred Systemic Therapy (DST) for Metastatic Renal Cell Carcinoma: Preliminary Prospective Experience

User Photo
kidneycancer

2 years
376 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Michael Roger Harrison, MD of Duke University presents Deferred Systemic Therapy (DST) for Metastatic Renal Cell Carcinoma: Preliminary Prospective Experience at the 2017 Kidney Cancer Association symposium in Miami, FL.
Up Next Autoplay
>